Citadel Advisors - ANACOR PHARMACEUTICALS INC ownership

ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 174 filers reported holding ANACOR PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ANACOR PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$16,783,000
-79.3%
313,988
-56.2%
0.02%
-76.1%
Q4 2015$81,047,000
+21.7%
717,428
+26.9%
0.09%
+39.7%
Q3 2015$66,569,000
+411.8%
565,531
+236.6%
0.06%
+472.7%
Q2 2015$13,008,000
+222.5%
167,993
+141.0%
0.01%
+175.0%
Q1 2015$4,033,000
+1566.5%
69,715
+829.2%
0.00%
Q4 2014$242,000
-97.0%
7,503
-97.7%
0.00%
-100.0%
Q3 2014$8,050,000
+3384.8%
328,977
+2755.7%
0.01%
Q1 2014$231,00011,5200.00%
Other shareholders
ANACOR PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 1,067,892$125,702,00041.75%
VHCP Management, LLC 1,178,474$138,718,00035.56%
Palo Alto Investors LP 2,579,154$303,592,00014.60%
Baker Brothers Advisors 4,135,412$486,779,0004.50%
APIS CAPITAL ADVISORS, LLC 23,000$2,708,0003.75%
EMORY UNIVERSITY 11,096$1,306,0003.64%
Atika Capital Management LLC 61,000$7,180,0003.52%
KINGDON CAPITAL MANAGEMENT, L.L.C. 488,912$57,550,0002.78%
Segantii Capital Management Ltd 100,000$11,134,0002.55%
NEXT CENTURY GROWTH INVESTORS LLC 428,835$50,478,0002.10%
View complete list of ANACOR PHARMACEUTICALS INC shareholders